AcceleDev logo — Leading CDMO with small molecule synthetic chemistry R&D, pr...

AcceleDev

Leading CDMO with small molecule synthetic chemistry R&D, process development & commercial scale production facilities.

Founded 2003 United States Cranbury, United States 15 employees Manufacturing, Pharmaceutical

General Information

Company Name AcceleDev
Founded Year 2003
Location United States Cranbury, United States +2
Employees 15
Industries Manufacturing, Pharmaceutical
Social

Get notified when AcceleDev moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About AcceleDev

AcceleDev is a leading Contract Development and Manufacturing Organization (CDMO) specializing in small molecule synthetic chemistry research, process development, and commercial scale production. Established in 2003 in the United States, the company operates in the manufacturing and pharmaceutical industries with facilities in the US and China. With a strong focus on supporting pharmaceutical partners' API programs from preclinical stages to commercialization, AcceleDev offers a comprehensive range of services including process chemistry design, API process research and development, analytical method development, and commercial production within high-quality multi-purpose facilities. Renowned for its expertise and ability to tackle complex projects, AcceleDev has successfully completed thousands of projects over its twenty-year history. The company's commitment to intellectual creativity, integrity, and finesse has earned it a strong reputation, with partners entrusting AcceleDev to develop scalable synthesis models within tight turnaround times. With a customer-first approach, AcceleDev not only meets partners' Chemistry, Manufacturing, and Control requirements but also provides supply chain management services. The company's dedication to innovation and accelerating its partners' success sets it apart in the CDMO space. As AcceleDev continues to grow and expand its operations, its focus on delivering high-quality, innovative solutions positions it as a key player in the industry.

Taxonomy: CDMO, Chemical Synthesis, Process Development, API Production, Pharmaceutical Manufacturing, R&D, Pilot Scale-Up, Quality Control, Custom Synthesis, Small Molecule Chemistry, US-China Facilities, Analytical Method Development, Commercial Scale Production, Chemical Raw Materials

No funding data available for AcceleDev yet.

Get notified when AcceleDev raises funding

AcceleDev Alternatives & Competitors

AcceleDev vs

Strive to be your first choice of a chemistry service provider based on specialized and innovative s...

Series C
23 employees
Biotechnology, Pharmaceutical
AcceleDev vs

Research for tomorrow

4 employees
Manufacturing, Pharmaceutical
AcceleDev vs

Small Molecule CRO/CDMO Service Provider

35 employees
Manufacturing, Pharmaceutical
Also compare with: AcceleDev vs MINAKEM MINAKEM

FAQ About AcceleDev

Leading CDMO with small molecule synthetic chemistry R&D, process development & commercial scale production facilities.
AcceleDev was founded in 2003.
AcceleDev is headquartered in Cranbury, United States.
AcceleDev operates in the following industries: Manufacturing, Pharmaceutical.
AcceleDev has approximately 15 employees.
Top alternatives and competitors to AcceleDev include Bellen Chemistry Co., Ltd., Rane Pharmaceutical Inc, PharmaResources, Apex Molecular Ltd, NunaBio Limited. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AcceleDev and Bellen Chemistry Co., Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors AcceleDev and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy